Breaking News
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
September 25, 2018 - Fracture causes bone density losses throughout the body
September 25, 2018 - Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder
September 25, 2018 - Hybrid theranostic complex shows high therapeutic efficacy against tumor cells
September 25, 2018 - FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
September 25, 2018 - Toxicological evaluation and dosimetry estimation of potential PET radiotracer
September 25, 2018 - 5 obstacles parents commonly face in child obesity treatment and how to overcome them
September 25, 2018 - Immunologist to study how Chikungunya causes devastating effects in older adults
September 25, 2018 - Rural borderland communities vulnerable to high stress impacting mental and physical health
September 25, 2018 - SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship
September 25, 2018 - Common painkiller not effective in controlling chronic pain after traumatic nerve injury
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - Using multi-level approach to reduce underage drinking among youths on rural reservations
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
Scaling back Obamacare will make the opioid crisis worse

Scaling back Obamacare will make the opioid crisis worse

image_pdfDownload PDFimage_print

There’s been much talk in the U.S. about fixing the opioid crisis.

In October, President Donald Trump declared the situation a public health emergency and set up a commission on opioids. On Feb. 9, Congress finally took action by allocating US$6 billion for substance abuse treatment in the budget bill. Though a step in the right direction, many experts argue that it’s still a drop in the bucket given the extent of the epidemic.

These funds will undoubtedly help states expand substance abuse services, but their impact will depend on the robustness of our current health care system. As a social worker who has witnessed addiction firsthand, I know the country needs a health care system that treats the whole person, rather than just his or her substance use disorder.

This concept drove many provisions of the Affordable Care Act, which seeks to improve access and quality of services for people suffering from drug dependence. The ACA also promotes integrated health care, the systematic coordination of physical and behavioral care.

By undermining the ACA, Trump and the GOP are taking away one of the health care system’s best tools for improving the lives of those with addiction.

ACA and access to care

When the ACA passed in 2010, 62.5 million people gained access to mental health and substance abuse services for the first time.

By requiring that the essential benefits package include equal coverage for health and behavioral health conditions for both inpatient and outpatient care, the ACA significantly increased the reach of a 2008 law that applied only to big employer plans.

Many Americans also gained access to mental health and substance use benefits if their states opted to expand Medicaid under the ACA. By 2015, Medicaid covered 38 percent of the 2 million people with opioid dependence. However, that still left 20 percent uninsured, many of whom live in states that didn’t expand Medicaid.

With greater access has come increased treatment rates. Clinics under the National Council on Behavioral Health Care now treat 30,000 people a year for substance use disorders, versus 9,000 prior to the ACA. Many states expanded their Medicaid programs to include medication-assisted treatment, an effective approach that combines medication, such as Naltrexone or methadone, with counseling.

However, some Republicans go so far as to claim that Medicaid expansion caused the opioid epidemic. Drug-related deaths have continued to rise and are higher on average in states that expanded Medicaid under the ACA. People on Medicaid are also more likely to be on pain medication.

But the fact that more people are on pain medication does not prove that more people on Medicaid misuse opioids. People on Medicaid have more chronic conditions and pain than the general population and require more pain treatment. Moreover, these state trends in drug-related deaths were well-established before 2010, when the ACA went into effect.

Altogether the data show that, while access to health care is a necessary step, it’s not sufficient to solve the problem. What also matters is the way we deliver care.

Substance use and physical health

In addition to improving access and coverage, the ACA aims to redesign the way Americans receive health care.

Physical and mental health are intertwined, but our health care system has long treated symptoms in isolation. There are even separate government agencies to oversee health, mental health and substance abuse services at the federal, state and local level.

Opioid dependence is arguably one of the most egregious examples of the damage wrought by treating one symptom without considering the whole person. During the crisis, new cases of hepatitis C from opioid use tripled, Indiana experienced an HIV outbreak and deaths from overdose skyrocketed. People with substance use disorders are at high risk for other ailments, such as heart disease, asthma, gastrointestinal disorders and skin infections.

Yet behavioral health care providers have neglected the physical health needs of the people with mental health and substance use disorders, leading to alarming mortality rates. Conversely, primary care providers have not paid attention to behavioral health. In the case of opioid addiction, this has led to dangerous prescribing practices to manage pain.

People with substance use disorders and mental illnesses make 12 million visits annually to emergency departments. These visits and subsequent hospitalizations are predominantly for medical care, not psychiatric care, and most importantly could often have been prevented with good primary care.

Under the ACA, millions of federal dollars have been awarded to health care systems find innovative ways to integrate care. For example, accountable care organizations are groups of hospitals, doctors and other providers who take on the cost of caring for an enrolled population and can share any savings they generate. Some models go further by actually locating primary and behavioral health clinics together, so people can have a one-stop shopping experience for all their health needs.

Such models provide financial incentives for systems to coordinate primary and behavioral care. Early evidence suggests that accountable care organizations improve the quality of care and reduce hospitalizations.

The ACA also increased funding for preventive services, such as screenings for substance abuse in community settings.

Danger ahead

During the 2016 elections, the repeal of the ACA became a rallying cry for Trump.

Yet Congress has not managed to overturn it. Instead, the attack on the ACA has become piecemeal. Trump has cut funding to promote enrollment in marketplace insurance, offered states the option to implement Medicaid waivers that undermine benefits and constantly threatened to cut cost-sharing payments to insurers.

The most significant attack came recently as part of the tax overhaul bill. This bill repealed the individual mandate, meaning people can no longer be penalized for not having health care insurance. Many experts are concerned that this will exacerbate the fragility of insurance markets. Furthermore, the bill eliminated key health care taxes that fund innovation to improve service quality and reduce costs.

While we have seen the opioid epidemic rise under the ACA, the crisis could have been worse without it. What’s more, system integration is complicated and takes time. Even with the full support of the administration, Americans would not have seen the full benefits of these reforms yet.


Explore further:
More access to opioid treatment programs needed in Southeast, says study

Provided by:
The Conversation

Tagged with:

About author

Related Articles